{"id":35129,"date":"2026-04-23T09:26:33","date_gmt":"2026-04-23T03:56:33","guid":{"rendered":"https:\/\/signalz.pro\/?post_type=media-review&#038;p=35129"},"modified":"2026-04-23T09:46:07","modified_gmt":"2026-04-23T04:16:07","slug":"auto-draft-3862","status":"publish","type":"media-review","link":"https:\/\/signalz.pro\/media-review\/auto-draft-3862\/","content":{"rendered":"<div class=\"elementor-element elementor-element-626cf91 e-flex e-con-boxed e-con e-parent e-lazyloaded\" data-id=\"626cf91\" data-element_type=\"container\">\n<div class=\"e-con-inner\">\n<div class=\"elementor-element elementor-element-1dc978b elementor-widget elementor-widget-elementskit-heading\" data-id=\"1dc978b\" data-element_type=\"widget\" data-settings=\"{&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"elementskit-heading.default\">\n<div class=\"ekit-wid-con\">\n<div class=\"ekit-heading elementskit-section-title-wraper text_left ekit_heading_tablet- ekit_heading_mobile-text_center\">\n<p>Warning-<\/p>\n<p data-start=\"16\" data-end=\"328\">as we can see that in the opening, pharma space is showing strength and <strong data-start=\"101\" data-end=\"111\">Biocon<\/strong> is holding bullish momentum after recent positive turnaround in earnings and improving financial performance, where company posted strong profit growth and got upgraded outlook<\/p>\n<p data-start=\"330\" data-end=\"535\">Technically, stock is trading above key EMAs indicating strength, <strong data-start=\"396\" data-end=\"428\">MACD is in bullish crossover<\/strong> and momentum is building, while <strong data-start=\"461\" data-end=\"487\">RSI is near 60\u201365 zone<\/strong> showing upside room without being overbought<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"elementor-element elementor-element-7f0d5ad e-flex e-con-boxed e-con e-parent e-lazyloaded\" data-id=\"7f0d5ad\" data-element_type=\"container\">\n<div class=\"e-con-inner\">\n<div class=\"elementor-element elementor-element-9ad067d elementor-widget elementor-widget-text-editor\" data-id=\"9ad067d\" data-element_type=\"widget\" data-settings=\"{&quot;ekit_we_effect_on&quot;:&quot;none&quot;}\" data-widget_type=\"text-editor.default\">\n<p><strong>Disclaimer<\/strong>\u2013 Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.<\/p>\n<p><strong>Disclosure<\/strong>\u2013 Investments in securities market are subject to market risks, read all the related documents carefully before investing.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"comment_status":"closed","ping_status":"closed","template":"","media-category":[9],"media-subscription":[],"call-tags":[],"class_list":["post-35129","media-review","type-media-review","status-publish","hentry","media-category-stock-exchange"],"acf":[],"_links":{"self":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/35129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review"}],"about":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/types\/media-review"}],"replies":[{"embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/comments?post=35129"}],"version-history":[{"count":2,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/35129\/revisions"}],"predecessor-version":[{"id":35157,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-review\/35129\/revisions\/35157"}],"wp:attachment":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media?parent=35129"}],"wp:term":[{"taxonomy":"media-category","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-category?post=35129"},{"taxonomy":"media-subscription","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media-subscription?post=35129"},{"taxonomy":"call-tags","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/call-tags?post=35129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}